National Institute for Health and Clinical Excellence (NICE)
Digital mental health tech for children and young people recommended by NICE in first rapid healthtech guidance
Four digital technologies that can help children and young people with mild to moderate symptoms of anxiety or low mood have been recommended for use in the NHS once they achieve regulatory approval.
The guided self-help digital cognitive behavioural therapy (CBT) technologies can be used as an initial treatment option for those aged 5 to 18 while evidence is being generated.
These technologies will be able to be used once they have been given Digital Technology Assessment Criteria (DTAC) approval by NHS England.
This topic is the first to be published as final early value assessment (EVA) guidance, new NICE guidance that provides conditional recommendations on promising health technologies that have the potential to address national unmet need.
This evaluation looks at promising technologies that can be used within the NHS while further evidence is generated to enable earlier access for patients. NICE guidance will then be reviewed to include this additional evidence and make a recommendation on the routine use across the NHS.
Early value assessment guidance is expected to take around 6 months to produce. This is quicker than the current time scale for NICE medical technologies guidance.
Mark Chapman, interim director of medical technology and digital evaluation at NICE, said: “Patient experts told our committee that mental health services are in high demand, access varies widely across the country, and there is an unmet need when it comes to receiving treatment while on waiting lists to see specialists. These four technologies offer low risk options to children and young people who need to begin treatment as soon as possible.
“This guidance shows how NICE is focussing on what matters most by getting the best care to patients fast.”
Health and Social Care Secretary Steve Barclay said: “These four technologies, using games, videos and quizzes, represent a promising step forward for new treatment options for children and young people, with early evidence showing they could help improve symptoms of anxiety or low mood.
“It is incredibly important children and young people can access mental health services when they need it, and these new guided self-help tools will allow those between 5 and 18 to learn techniques for support when they are available in future.
"This builds upon work already in place with nearly 300 mental health support teams in place in around 4,700 schools and colleges across the country."
The four self-guided products offer a mix of games, videos and quizzes, based on CBT principles, help children and young people learn techniques to better understand and manage their symptoms of anxiety or low mood.
An initial assessment with a healthcare professional is needed before using these technologies to make sure they are suitable and children and young people are then checked on a regular basis.
Digital CBT is delivered via mobile phones, tablets, or computers and can be accessed remotely and offers flexible access, greater privacy, increased convenience, and increased capacity. It may be particularly appealing to children and young people who are typically regular users of digital technologies such as smartphones and tablets.
Children and young people will have regular support from a healthcare professional and safeguarding and risk management processes must be in place. This means that if the treatment is not working and symptoms are getting worse, it will be identified quickly, lowering the risks to the child or young person.
An independent NICE committee has recommended the use of:
- Lumi Nova (BfB labs)
- Online Social anxiety Cognitive therapy for Adolescents (OSCA)
- Online Support and Intervention for child anxiety (OSI).
- Space from anxiety for teens, space from low mood for teens, space from low mood and anxiety for teens (Silvercloud).
It will be for the local NHS to determine how they wish to commission these new treatment options once they are DTAC compliant. The NICE committee believes the four technologies could offer a useful additional treatment option for around one million children and young people who may not be able to access current treatment or are on a waiting list and so not currently having treatment.
Early evidence suggests that digital CBT technologies may improve symptoms of anxiety for children and young people with mild to moderate symptoms of anxiety or low mood.
NICE believes that earlier treatment could reduce the demand on other treatment options such as face-to-face CBT and potentially prevent progression to more severe symptoms which could be more costly to treat.
Original article link: https://www.nice.org.uk/news/article/digital-mental-health-tech-for-children-and-young-people-recommended-by-nice-in-first-rapid-healthtech-guidance
Latest News from
National Institute for Health and Clinical Excellence (NICE)
NICE welcomes life sciences review recommendations26/05/2023 16:05:00
NICE’s priority is to get the best care to patients fast while ensuring value for the taxpayer.
Testing could help prevent further strokes in people with gene variant19/05/2023 12:20:00
People who have had an ischaemic stroke or transient ischaemic attack (TIA) should have a genetic test to find out whether they can be treated with a drug which reduces the risk of further strokes, NICE has said
NICE draft guidance recommends new treatment for chronic heart failure18/05/2023 13:05:00
Up to 150,000 people in England with a type of chronic heart failure are set to benefit from a new treatment following its approval by NICE
Nine treatment options to be made available for adults with depression or an anxiety disorder16/05/2023 16:15:00
Six digitally enabled therapies for adults with anxiety disorders and three for adults with depression have been recommended for use in the NHS while further data is gathered, NICE has said.
Hundreds of children with type 2 diabetes to be offered choice of two life changing technologies11/05/2023 15:25:00
Hundreds of children with type 2 diabetes who currently manage their condition with the ‘burdensome’, ‘tiring’, and ‘stressful’ task of finger prick testing several times a day could be offered a choice between two ‘life changing’ technologies to virtually automate the process, NICE has said
Two new personalised immunotherapy treatments for aggressive forms of blood cancer recommended for the Cancer Drugs Fund27/04/2023 11:20:00
NICE recommends two CAR-T therapies, both given as one-off infusions, to treat aggressive forms of blood cancer
NICE collaborates with international partner agencies to streamline the confidential marking process25/04/2023 14:15:00
NICE, the Canadian Agency for Drugs and Technologies in Health and the US’s Institute for Clinical and Economic Review yesterday (24 April 2023) announced they are changing the way confidential information about health technologies is handled to streamline processes and increase transparency.
How ‘surrogate outcomes’ influence long-term health outcomes17/04/2023 14:15:00
Blog posted by: Dr Jacoline Bouvy, technical director, NICE Scientific Advice, 13 April 2023.
NICE final draft guidance recommends olaparib for early breast cancer and metastatic prostate cancer following new commercial deals06/04/2023 16:15:00
Ground-breaking commercial deals for anti-cancer medicine olaparib have paved the way for hundreds to benefit in final draft guidance published today (6 April 2023) by NICE that recommends it for some types of early breast cancer and advanced prostate cancer